National Health (Prescriber Bag Supplies) Determination 2024 PB 29 of 2024 made under sections 93 and 93AB of the National Health Act 1953 Compilation No. 2 Compilation date: 1 February 2025 Includes amendments: F2025L00065 About this compilation This compilation This is a compilation of the National Health (Prescriber Bag Supplies) Determination 2024 that shows the text of the law as amended and in force on 1 February 2025 (the compilation date). The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law. Uncommenced amendments The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law. Application, saving and transitional provisions for provisions and amendments If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes. Editorial changes For more information about any editorial changes made in this compilation, see the endnotes. Modifications If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law. Self‑repealing provisions If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes. Contents Part 1—Preliminary 1 Name 3 Authority 4 Definitions 5 References to a pharmaceutical benefit that has a drug in a relevant form Part 2—Authorisation of practitioners and maximum quantity (number of units) 6 Authorisation of practitioners to supply pharmaceutical benefits 7 Maximum quantity (number of units) Schedule 1—Pharmaceutical benefits that may be supplied by authorised suppliers Endnotes Endnote 1—About the endnotes Endnote 2—Abbreviation key Endnote 3—Legislation history Endnote 4—Amendment history Part 1—Preliminary 1 Name (1) This instrument is the National Health (Prescriber Bag Supplies) Determination 2024. (2) This instrument may also be cited as PB 29 of 2024. 3 Authority This instrument is made under sections 93 and 93AB of the National Health Act 1953. 4 Definitions Note 1: Under subsection 4(1A) of the Act, a word or phrase defined for the purposes of the Health Insurance Act 1973 has the meaning that it would have if used in that Act. Expressions used in this instrument that are defined in that Act include 'medical practitioner'. In this instrument: Act means the National Health Act 1953. authorised nurse practitioner has the same meaning as in Part VII of the Act. pharmaceutical benefit has the same meaning as in Part VII of the Act. pharmaceutical benefit has a drug has the same meaning as in Part VII of the Act. pharmaceutical benefit that has a drug in a relevant form: see section 5. 5 References to a pharmaceutical benefit that has a drug in a relevant form A reference in this instrument to a pharmaceutical benefit that has a drug in a relevant form is a reference to a pharmaceutical benefit that has a drug mentioned in an item in Schedule 1 in the column headed "Listed Drug" in the form mentioned for that drug in the column in Schedule 1 headed "Form". Part 2—Authorisation of practitioners and maximum quantity (number of units) 6 Authorisation of practitioners to supply pharmaceutical benefits (1) For the purposes of subsection 93(1) of the Act, a medical practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials "MP" are mentioned for that drug in that form in the column in Schedule 1 headed "Prescriber Bag Supplier". (2) For the purposes of subsection 93AB(1) of the Act, an authorised nurse practitioner is authorised to supply a pharmaceutical benefit that has a drug in a relevant form if the initials "NP" are mentioned for that drug in that form in the column in Schedule 1 headed "Prescriber Bag Supplier". 7 Maximum quantity (number of units) (1) This section determines the maximum number of units of a pharmaceutical benefit that has a drug in a relevant form which may be obtained by a medical practitioner or an authorised nurse practitioner (a practitioner) in a calendar month for the purposes of subsection 93(2) and subsection 93AB(2) of the Act. (2) The maximum number of units is the number of units mentioned in the column in Schedule 1 headed "Maximum Quantity" for that drug in that form. (3) Despite subsection (2), if a practitioner has already obtained 1 or more units of a pharmaceutical benefit that has a drug in a relevant form in a group in the same calendar month, the maximum number of units of any other pharmaceutical benefit that has a drug in a relevant form in that group is zero for that calendar month. (4) For this section, a group is each pharmaceutical benefit that has a drug in a relevant form which has the same number mentioned for the drug and form in the column in Schedule 1 headed "Group Number". Schedule 1—Pharmaceutical benefits that may be supplied by authorised suppliers Group Number Listed Drug Form Prescriber Bag Supplier Maximum Quantity 1 Adrenaline (epinephrine) Injection 1 mg (as acid tartrate) in 1 mL (1 in 1,000) MP, NP 5 3 Atropine Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL MP, NP 10 58 Benzathine benzylpenicillin Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre‑filled syringe MP, NP 10 58 Benzathine benzylpenicillin Powder for injection 1,200,000 units with diluent 5 mL (S19A) MP, NP 10 31 Benzatropine Injection containing benzatropine mesilate 2 mg in 2 mL MP, NP 5 17 Benzylpenicillin Powder for injection 600 mg (as sodium) MP, NP, MW 5 32 Benzylpenicillin Powder for injection 3 g (as sodium) MP, NP, MW 1 4 Chlorpromazine Injection containing chlorpromazine hydrochloride 50 mg in 2 mL MP, NP 10 34 Clonazepam Oral liquid 2.5 mg per mL, 10 mL MP, NP 1 25 Diphtheria and tetanus vaccine, adsorbed, diluted for adult use Injection 0.5 mL in pre‑filled syringe MP, NP 10 10 Furosemide Injection 20 mg in 2 mL MP, NP 5 60 Furosemide Tablet 20 mg MP, NP 50 26 Glucagon Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe MP, NP 1 30 Glyceryl Trinitrate Sublingual spray (pump pack) 400 micrograms per dose, 200 doses MP, NP 1 4 Haloperidol Injection 5 mg in 1 mL MP, NP 10 12 Hydrocortisone Injection 100 mg (as sodium succinate) with 2 mL solvent MP, NP 2 12 Hydrocortisone Injection 250 mg (as sodium succinate) with 2 mL solvent MP, NP 1 33 Hyoscine Injection containing hyoscine butylbromide 20 mg in 1 mL MP, NP 5 54 Lidocaine Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL MP, NP, MW 5 35 Methoxyflurane Liquid for inhalation 999 mg per g, 3 mL (with inhaler) MP 1 18 Metoclopramide Injection containing 10 mg metoclopramide hydrochloride (as monohydrate) in 2 mL MP, NP 10 53 Midazolam Injection 5 mg (as hydrochloride) in 1 mL MP, NP 10 62 Molnupiravir Capsule 200 mg MP, NP 80 14 Morphine Injection containing morphine hydrochloride trihydrate 10 mg in 1 mL MP, NP 5 14 Morphine Injection containing morphine hydrochloride trihydrate 20 mg in 1 mL MP, NP 5 14 Morphine Injection containing morphine sulfate pentahydrate 15 mg in 1 mL MP, NP 5 14 Morphine Injection containing morphine sulfate pentahydrate 30 mg in 1 mL MP, NP 5 57 Naloxone Injection containing naloxone hydrochloride 400 micrograms in 1 mL ampoule MP, NP, MW 10 61 Nirmatrelvir and ritonavir Pack containing 4 tablets nirmatrelvir 150 mg and 2 tablets ritonavir 100 mg, 5 MP, NP 2 55 Phytomenadione Injection 10 mg in 1 mL MP 5 18 Prochlorperazine Injection containing prochlorperazine mesilate 12.5 mg in 1 mL MP, NP, MW 10 19 Promethazine Injection containing promethazine hydrochloride 50 mg in 2 mL MP, NP, MW 10 59 Salbutamol Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 MP, NP 1 59 Salbutamol Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 (S19A) MP, NP 1 59 Salbutamol Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 30 MP, NP 1 28 Salbutamol Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20 MP, NP 1 28 Salbutamol Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30 MP, NP 1 59 Salbutamol Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC‑free formulation) MP, NP 1 16 Tramadol Injection containing tramadol hydrochloride 100 mg in 2 mL MP, NP 5 Endnotes Endnote 1—About the endnotes The endnotes provide information about this compilation and the compiled law. The following endnotes are included in every compilation: Endnote 1—About the endnotes Endnote 2—Abbreviation key Endnote 3—Legislation history Endnote 4—Amendment history Abbreviation key—Endnote 2 The abbreviation key sets out abbreviations that may be used in the endnotes. Legislation history and amendment history—Endnotes 3 and 4 Amending laws are annotated in the legislation history and amendment history. The legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation. The amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law. Editorial changes The Legislation Act 2003 authorises First Parliamentary Counsel to make editorial and presentational changes to a compiled law in preparing a compilation of the law for registration. The changes must not change the effect of the law. Editorial changes take effect from the compilation registration date. If the compilation includes editorial changes, the endnotes include a brief outline of the changes in general terms. Full details of any changes can be obtained from the Office of Parliamentary Counsel. Misdescribed amendments A misdescribed amendment is an amendment that does not accurately describe how an amendment is to be made. If, despite the misdescription, the amendment can be given effect as intended, then the misdescribed amendment can be incorporated through an editorial change made under section 15V of the Legislation Act 2003. If a misdescribed amendment cannot be given effect as intended, the amendment is not incorporated and "(md not incorp)" is added to the amendment history. Endnote 2—Abbreviation key ad = added or inserted o = order(s) am = amended Ord = Ordinance amdt = amendment orig = original c = clause(s) par = paragraph(s)/subparagraph(s) C[x] = Compilation No. x /sub‑subparagraph(s) Ch = Chapter(s) pres = present def = definition(s) prev = previous Dict = Dictionary (prev…) = previously disallowed = disallowed by Parliament Pt = Part(s) Div = Division(s) r = regulation(s)/rule(s) ed = editorial change reloc = relocated exp = expires/expired or ceases/ceased to have renum = renumbered effect rep = repealed F = Federal Register of Legislation rs = repealed and substituted gaz = gazette s = section(s)/subsection(s) LA = Legislation Act 2003 Sch = Schedule(s) LIA = Legislative Instruments Act 2003 Sdiv = Subdivision(s) (md) = misdescribed amendment can be given SLI = Select Legislative Instrument effect SR = Statutory Rules (md not incorp) = misdescribed amendment Sub‑Ch = Sub‑Chapter(s) cannot be given effect SubPt = Subpart(s) mod = modified/modification underlining = whole or part not No. = Number(s) commenced or to be commenced Endnote 3—Legislation history Name Registration Commencement Application, saving and transitional provisions National Health (Prescriber Bag Supplies) Determination 2024 (PB 29 of 2024) 28 Mar 2024 (F2024L00414) 1 Apr 2024 (s 2(1) item 1) National Health (Prescriber Bag Supplies) Amendment (May Update) Determination 2024 (PB 42 of 2024) 30 Apr 2024 (F2024L00503) 1 May 2024 (s 2(1) item 1) — National Health (Prescriber bag supplies) Amendment (February Update) Determination 2025 (PB 4 of 2025) 31 Jan 2025 (F2025L00065) 1 Feb 2025 (s 2(1) item 1) — Endnote 4—Amendment history Provision affected How affected Part 1 s 2..................... rep LA s 48D Schedule 1 Schedule 1................ am F2024L00503; F2025L00065